EP1309330 - PHOTOSENSITIZERS WITH LIGAND TARGETING PROPERTIES FOR TUMOR THERAPY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 30.01.2009 Database last updated on 03.08.2024 | Most recent event Tooltip | 30.01.2009 | No opposition filed within time limit | published on 04.03.2009 [2009/10] | Applicant(s) | For all designated states CeramOptec GmbH Siemensstrasse 44 53121 Bonn / DE | [2003/20] | Inventor(s) | 01 /
MOSER, Joerg, G. Lise-Meitner Strasse 33 40591 Dusseldorf / DE | [2003/20] | Application number, filing date | 01952201.0 | 22.06.2001 | [2003/20] | WO2001US20086 | Priority number, date | US20000599660 | 22.06.2000 Original published format: US 599660 | US20000745458 | 21.12.2000 Original published format: US 745458 | [2003/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0197814 | Date: | 27.12.2001 | Language: | EN | [2001/52] | Type: | A1 Application with search report | No.: | EP1309330 | Date: | 14.05.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.12.2001 takes the place of the publication of the European patent application. | [2003/20] | Type: | B1 Patent specification | No.: | EP1309330 | Date: | 26.03.2008 | Language: | EN | [2008/13] | Search report(s) | International search report - published on: | US | 27.12.2001 | (Supplementary) European search report - dispatched on: | EP | 11.11.2004 | Classification | IPC: | A61K31/5415, A61K41/00, A61K47/48, A61P35/00 | [2007/45] | CPC: |
A61K31/724 (EP);
A61K31/5415 (EP);
A61K41/0057 (EP);
A61K41/0071 (EP);
A61P35/00 (EP)
|
Former IPC [2005/01] | A61K31/5415, A61K41/00, A61K47/48 | ||
Former IPC [2003/20] | A61K31/5415 | Designated contracting states | DE, GB [2004/22] |
Former [2003/20] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR | Title | German: | PHOTOSNESIBILISIERENDESUBSTANZENMIT LIGAND-TARGETING EIGENSCHAFTEN ZUR TUMORTHERAPIE | [2003/20] | English: | PHOTOSENSITIZERS WITH LIGAND TARGETING PROPERTIES FOR TUMOR THERAPY | [2003/20] | French: | PHOTOSENSIBILISANTS POUR TH RAPIE ANTITUMORALE CAPABLES DE CIBLAGE LIGANTAIRE | [2003/20] | Entry into regional phase | 22.01.2003 | National basic fee paid | 22.01.2003 | Search fee paid | 22.01.2003 | Designation fee(s) paid | 22.01.2003 | Examination fee paid | Examination procedure | 16.01.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 22.01.2003 | Examination requested [2003/20] | 06.04.2005 | Despatch of a communication from the examining division (Time limit: M04) | 20.09.2005 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 16.11.2005 | Reply to a communication from the examining division | 15.03.2006 | Despatch of a communication from the examining division (Time limit: M04) | 06.07.2006 | Reply to a communication from the examining division | 06.03.2007 | Despatch of a communication from the examining division (Time limit: M06) | 03.09.2007 | Reply to a communication from the examining division | 17.10.2007 | Communication of intention to grant the patent | 11.02.2008 | Fee for grant paid | 11.02.2008 | Fee for publishing/printing paid | Opposition(s) | 30.12.2008 | No opposition filed within time limit [2009/10] | Request for further processing for: | 16.11.2005 | Request for further processing filed | 16.11.2005 | Full payment received (date of receipt of payment) Request granted | 02.12.2005 | Decision despatched | Fees paid | Renewal fee | 30.06.2003 | Renewal fee patent year 03 | 30.06.2004 | Renewal fee patent year 04 | 30.06.2005 | Renewal fee patent year 05 | 30.06.2006 | Renewal fee patent year 06 | 02.07.2007 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]WO0151524 (CERAMOPTEC IND INC [US]) [E] 1* claim - *; | [X] - MOSER J G ET AL, "Cyclodextrin Dimers Used to Prevent Side Effects of Photochemotherapy and General Tumor Therapy", JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, KLUWER, DORDRECHT, NL, (1996), vol. 25, ISSN 0923-0750, pages 29 - 34, XP002097236 [X] 1-11 * figure 3 * DOI: http://dx.doi.org/10.1007/BF01041530 | [X] - RUEBNER, A. ET AL, "Carrier systems in PDT II: Accumulation strategies of biotin-avidin coupled photosensitizers developed on cultured tumor cells", PROCEEDINGS OF SPIE-THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING , 2625(PHOTOCHEMISTRY: PHOTODYNAMIC THERAPY AND OTHER MODALITIES), 328-332 CODEN: PSISDG; ISSN: 0277-786X, (1996), XP008037924 [X] 1-11 * figure 1 * DOI: http://dx.doi.org/10.1117/12.230957 | [DX] - HIRTH, ANDREAS ET AL, "New biotinylated phthalocyanines for the photodynamic therapy of cancer", PROCEEDINGS OF SPIE-THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING , 3191(PHOTOCHEMOTHERAPY: PHOTODYNAMIC THERAPY AND OTHER MODALITIES III), 309-314 CODEN: PSISDG; ISSN: 0277-786X, (1997), XP008037922 [DX] 1-11 * page 1 * DOI: http://dx.doi.org/10.1117/12.297819 | International search | [A]US5070081 (MAJID ABDUL [CA], et al) | [X] - CLINE ET AL., "beta-Cyclodextrin inclusion complexes with alpha-dlimineruthenium (II) photosensitizers", J. PHYS. CHEM., (1985), vol. 89, no. 1, pages 94 - 97, XP002947613 DOI: http://dx.doi.org/10.1021/j100247a023 | [X] - LOUKAS ET AL., "Characterization and photoprotection studies of a model gamma-cyclodextrin-included photolabile drug entrapped in liposomes incorporating light absorbers", J. PHYS. CHEM., (1995), vol. 99, no. 27, pages 11035 - 11040, XP002947614 DOI: http://dx.doi.org/10.1021/j100027a052 | [X] - RUEBNER ET AL., "A cyclodextrin dimer with a photocleavable linker as a possible carrier for the photosensitizer in photodynamic tumor therapy", PROC. NATL. ACAD. SCI. USA, (19991221), vol. 96, no. 26, pages 14692 - 14693, XP002947615 DOI: http://dx.doi.org/10.1073/pnas.96.26.14692 |